CalciMedica, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CalciMedica, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $31.00K.
- CalciMedica, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $777.00K.
- CalciMedica, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $968.00K, a 293.50% increase year-over-year.
- CalciMedica, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $47.00K.
- CalciMedica, Inc. stock issued during period, value, new issues for fiscal 2025 was $5.51M, a 11146.94% increase from fiscal 2024.
- CalciMedica, Inc. stock issued during period, value, new issues for fiscal 2024 was $49.00K, a 80.08% decline from fiscal 2023.
- CalciMedica, Inc. stock issued during period, value, new issues for fiscal 2023 was $246.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $31.00K 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $5.51M 10-K · filed 2026-03-03 | |
| 2025-09-30 | $777.00K 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $968.00K 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $49.00K 10-K · filed 2026-03-03 | |
| 2024-06-30 | $47.00K 10-Q · filed 2025-11-12 | $539.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-03-31 | $246.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $246.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $72.00K 10-Q · filed 2023-11-09 | |
| 2020-09-30 | $79.53M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |